CIK 0001607678 · Large accelerated filer
Viking Therapeutics, Inc.
Sign in to watch- Ticker
- VKTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 461073877
- Phone
- 858-704-4660
- Business address
- 9920 PACIFIC HEIGHTS BLVD, SUITE 500, SAN DIEGO, CA
- 4 Planned sale President & CEO sold 269,079 shares at an average $26.87 ($7,230,784)
- 4 Planned sale Director sold 25,000 shares at $28.05 ($701,250)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
- 8-K Event Results of operations
- 4 Planned sale President & CEO sold 85,000 shares at an average $24.71 ($2,100,750)
- 144 Insider Sale of Securities
- 4 Planned sale President & CEO sold 35,000 shares at $23.95 ($838,250)
- 144 Insider Sale of Securities
- SC 13G Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 4 Planned sale Director sold 30,000 shares at $23.05 ($691,500)
- 144 Insider Sale of Securities
- SC 13G/A Stake Amended Statement of Ownership
- 4 Shares withheld for taxes President & CEO gave up 254,192 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Operating Officer gave up 63,409 shares (to pay taxes)
- 4 Open-market sale Chief Financial Officer sold 15,000 shares at $17.90 ($268,500)
- 4 Derivatives Options or other derivatives
Page 10 of 33 · 652 filings